Risks of consuming ashwagandha: Usage tips and prohibitions

In previous posts on this blog, we have talked about the risks of consuming ashwagandha and its recommended use. But where does all this concern come from, and what does the science and regulations tell us?

What is ashwagandha?

Ashwagandha is a plant originally known in Ayurvedic medicine (traditional medicine of Indian origin), which has recently generated different debates among international authorities. It has recently gained popularity as an ingredient in food supplements. Its benefits include reducing stress, improving sleep and strengthening the immune system. However, the debate about the risks of consuming ashwagandha is growing in the scientific community, mainly due to a lack of conclusive studies on its side effects, especially when consumed long-term or in high doses. One of the main concerns is its possible impact on reproductive health. Some studies have suggested that long-term use of this ingredient may influence fertility, including both men and women. In addition, concerns have also been raised about its impact on thyroid hormones. However, these studies are not conclusive, but nevertheless, these warnings have led some regulatory agencies to recommend caution.

Ashwagandha ban in Europe

In Europe, the Danish Medicines Agency has banned the use of ashwagandha in food supplements because of these potential risks. The agency referred to possible toxicological effects, effects on sex hormones, metabolism, the central nervous system and the immune system. Since June 2024, Denmark has set up a working group to assess the effects of this ingredient on human health. On the other hand, in regions such as France and the Netherlands, far from banning it, health authorities have chosen to issue warnings and recommendations. These agencies recommend, given the risk of consuming ashwagandha, that sectors of the population, such as pregnant women, avoid consuming it. In 2013, the German Federal Institute for Risk Assessment published a risk assessment of several plant-based products used in food and food supplements, including ashwagandha. The conclusions of the report determine that more information is needed to make an assessment on this ingredient such as toxicological studies, historical exposure data or its dose-dependent impact. The European Food Safety Authority (EFSA) has not yet received an official mandate to carry out a comprehensive risk assessment on the risks of consuming ashwagandha in response to general concerns. However, the growing use of the plant in the European (and world) market is leading to increased pressure for more detailed research into its long-term effects.

Conclusions on the risks of taking ashwagandha

While ashwagandha continues to be appreciated for its potential benefits, concerns from international authorities highlight the importance of further research into its safety and potential risks. LegaleGo is constantly working with regulatory agencies to ensure that we are able to inform and act quickly in the event of any changes to regulations. We will keep you informed as new developments appear, and if you have any queries, please do not hesitate to contact us. Fill in the contact form or call us, and our team of experts in food regulations will advise you.